Feds Inject $142 Million into Auburn Biotech to Speed Vaccine Delivery

Automated transfer station at SiO2 in Auburn Two top federal biological research agencies today announced an agreement investing $142 million in an Auburn biotech to speed production of specially engineered vials for coronavirus vaccines. The Department of Defense’s Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense, along with…

Thank you for reading!

To continue reading this article you must be registered and logged into this site. If you already have an account please login now, otherwise you can click here to register for new account. Registration is FREE.

Login       Register

The latest Alabama business news delivered to your inbox